Literature DB >> 7811056

Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.

G A Breen1, J M Brocavich, J V Etzel, V Shah, P Schaefer, S Forlenza.   

Abstract

A prospective, randomized, crossover study was performed with seven healthy volunteers to address the effect of increased gastric pH on dapsone absorption. Subjects were randomized to receive a single 100-mg dose of dapsone or a single 100-mg dose of dapsone in addition to 30 ml of a high potency antacid 1 h before dapsone administration and hourly thereafter for a total of 10 doses. Dapsone concentrations in serum were measured periodically for 48 h. No statistical differences between the two regimens were noted when mean dapsone maximal initial concentrations, times to peak, and areas under the curve were compared. These data suggest that an increase in gastric pH has little or no effect on the absorption of dapsone in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811056      PMCID: PMC284721          DOI: 10.1128/AAC.38.9.2227

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  The pharmacokinetics of dapsone after oral administration to healthy volunteers.

Authors:  F A Pieters; J Zuidema
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men.

Authors:  A J Glazko; W A Dill; R G Montalbo; E L Holmes
Journal:  Am J Trop Med Hyg       Date:  1968-05       Impact factor: 2.345

4.  Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; E Quadros; S Beidas; M Elsakr; W Tom; D E Wilson; H P Dincsoy; P Cohen; E W Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

5.  Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

Authors:  J Mills; G Leoung; I Medina; P C Hopewell; W T Hughes; C Wofsy
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

6.  Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.

Authors:  K Carr; J A Oates; A S Nies; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

7.  Oral activated charcoal and dapsone elimination.

Authors:  P J Neuvonen; E Elonen; M J Mattila
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

8.  Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination.

Authors:  P J Neuvonen; E Elonen; E J Haapanen
Journal:  Acta Med Scand       Date:  1983

9.  Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; W Tom; D Lake-Bakaar; N Gupta; S Beidas; M Elsakr; E Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

10.  Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

View more
  1 in total

Review 1.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.